Business Context and Reporting Period
CorVel Corporation provides managed-care and medical cost-containment services, including claims administration, bill review, provider networks, case management and pharmacy services, primarily for workers’ compensation and auto claims.
Period clarification: The supplied filing is a Form 10-K for the fiscal year ended March 31, 2012, not a 2010 Q4 filing as indicated in the request metadata. Figures below reflect fiscal 2012 unless otherwise noted.
Financial Results and Position
| Metric | FY2012 | FY2011 |
|---|---|---|
| Revenue | $412.7 million | $380.7 million |
| Gross profit | $93.8 million | $96.6 million |
| Gross margin | 22.7% | 25.4% |
| Income before tax | $43.4 million | $37.4 million |
| Net income | $26.6 million | $24.7 million |
| Diluted EPS | $2.28 | $2.05 |
| Operating cash flow | $35.7 million | $45.1 million |
- Cost of revenue was $318.8 million, or 77.3% of revenue. Net margin was 6.4%.
- Cash and cash equivalents were $6.6 million; working capital was $36.5 million. Total assets were $171.9 million and total liabilities were $61.5 million.
- No debt was outstanding at year-end. A $10 million revolving credit facility was available, with $8 million of letters of credit issued separately; the facility was due to expire in September 2012.
- Investing activities used $23.3 million, primarily for $23.2 million of property and equipment additions, including increased software development. Financing activities used $18.1 million, including $21.6 million of share repurchases.
Material Changes Versus Prior Year
- Revenue increased 8.4%, led by claims-administration customers and growth in patient management services. Patient management revenue rose 11% to $198 million; network solutions revenue increased 6% to $215 million.
- Patient management grew to 49.3% of revenue from 47.0%, reflecting increased TPA services. Management expects TPA services to grow faster than other services.
- Gross profit declined 2.8% and gross margin fell 2.7 percentage points. Management attributed this to higher-margin business being replaced by lower-margin work, including TPA growth.
- General and administrative expense fell 14.8% to $50.4 million, mainly because FY2011 included a $9 million Louisiana litigation charge. Excluding that charge, G&A was approximately flat; systems costs rose to $28 million from $25 million.
- Operating cash flow declined by $9.4 million, mainly because accrued liabilities fell following the Louisiana settlement payment. Days sales outstanding improved to less than 43 days from less than 45.
- Share repurchases totaled 461,938 shares for $21.6 million, versus 715,975 shares for $30.6 million in FY2011. The board increased the program authorization to 16 million lifetime shares.
Outlook, Risks, Contingencies and Unusual Items
- Management said cash, expected operating funds and the credit facility were adequate for obligations and planned activities for at least the next 12 months. No numerical revenue or earnings guidance was provided.
- Management cautioned that gross margins would not improve without more higher-margin services or operating efficiencies. It also noted that future property and equipment spending may increase with revenue growth.
- Key risks include competition and customer insourcing, contract loss or nonrenewal, changes in workers’ compensation and healthcare regulation, declining claims volumes, labor cost pressures, litigation, and technology, data-security or service interruptions.
- The Louisiana class-action settlement for $9 million received final approval and became final on January 17, 2012; CorVel had paid the amount into escrow in July 2011. The separate Illinois Roche matter had a $2.8 million accrued settlement; remaining payments were expected to be completed by July 2012. Management said other ordinary-course litigation was not expected to be material in aggregate.
- The FY2011 comparison includes litigation charges, so reported net-income improvement in FY2012 is not solely indicative of operating growth. The FY2012 effective tax rate rose to 39% from 35%, in part because FY2011 included a tax benefit.
- Management reported effective disclosure controls and internal control over financial reporting; the auditor issued an unqualified opinion on the financial statements and internal controls.
Important Facts for Investors to Verify
- Confirm the filing period: this document reports FY2012 ended March 31, 2012, despite the request’s “2010 Q4” label.
- Assess whether TPA-led revenue growth can be sustained without further gross-margin erosion.
- Review cash conversion and capital allocation, including lower operating cash flow, ongoing software investment and share repurchases.
- Confirm renewal or replacement of the revolving credit facility, which was scheduled to expire in September 2012.
- Track completion of settlement-related dismissals and payments, and any subsequent litigation or regulatory developments.